The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death

Molecular Cancer Research

Volumn 8, Issue 4, 2010, Pages 539-553

  Borghouts, Corina ^a   Tittmann, Hanna ^a   Delis, Natalia ^a   Kirchenbauer, Marisa ^a   Brill, Boris ^a   Groner, Bernd ^a  

^a Institute for Biomedical Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT3; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN RPP C8; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PURIFICATION; TRANSCRIPTION TERMINATION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE THERAPY; HUMANS; MICE; MOLECULAR CHAPERONES; NEOPLASMS; PEPTIDES; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 77951164211     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0417     Document Type: Article

References (43)

1. Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662
2. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474-2488
3. Chen W, Daines MO, Khurana Hershey GK. Turning off signal transducer and activator of transcription (STAT): the negative regulation of STAT signaling. J Allergy Clin Immunol 2004;114:476-489, quiz 490.
4. Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J Leukoc Biol 2001;70:348-356
5. Frank DA. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007;251:199-210.
6. Haura EB, Turkson J, Jove R. Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2005;2:315-324
7. Chung CD, Liao J, Liu B, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997;278:1803-1805
8. Shuai K. Regulation of cytokine signaling pathways by PIAS proteins. Cell Res 2006;16:196-202.
9. Schmidt D, Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 2003;60:2561-2574
10. Shuai K, Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 2005;5:593-605.
11. Jang HD, Yoon K, Shin YJ, Kim J, Lee SY. PIAS3 suppresses NF-κB-mediated transcription by interacting with the p65/RelA subunit. J Biol Chem 2004;279:24873-24880
12. Rytinki MM, Kaikkonen S, Pehkonen P, Jääskeläinen T, Palvimo JJ. PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol Life Sci 2009;66:3029-3041
13. Liao J, Fu Y, Shuai K. Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-STAT1 interaction. Proc Natl Acad Sci U S A 2000;97:5267-5272
14. Brantley EC, Nabors LB, Gillespie GY, et al. Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin Cancer Res 2008;14:4694-4704
15. Yagil Z, Kay G, Nechushtan H, Razin E. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells. J Immunol 2009;182:2168-2175
16. Ogata Y, Osaka T, Naka T, et al. Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. Neoplasia 2006;8:817-825
17. Herrmann A, Vogt M, Mönnigmann M, et al. Nucleocytoplasmic shuttling of persistently activated STAT3. J Cell Sci 2007;120:3249-3261 Epub 2007 Aug 28.
18. Wible BA, Wang L, Kuryshev YA, Basu A, Haldar S, Brown AM. Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3β in prostate cancer cells. J Biol Chem 2002;277:17852-17862 Epub 2002 Mar 4.
19. Jing N, Tweardy DJ. Targeting STAT3 in cancer therapy. Anticancer Drugs 2005;16:601-607
20. Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007;7:91-107.
21. Hetschko H, Voss V, Horn S, Seifert V, Prehn JH, Kögel D. Pharmacological inhibition of Bcl-2 family members reactivates TRAILinduced apoptosis in malignant glioma. J Neurooncol 2008;86: 265-272 Epub 2007 Oct 9.
22. Duval D, Duval G, Kedinger C, Poch O, Boeuf H. The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. FEBS Lett 2003;554:111-118
23. Borghouts C, Kunz C, Delis N, Groner B. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol Cancer Res 2008;6:267-281
24. Ma KW, Au SW, Waye MM. Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 (hnRNP A2/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells. Cell Biochem Funct 2009;27:228-237
25. Wang L, Banerjee S. Differential PIAS3 expression in human malignancy. Oncol Rep 2004;11:1319-1324
26. Nakagawa K, Yokosawa H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett 2002;530:204-208
27. Baxter FO, Neoh K, Tevendale MC. The beginning of the end: death signaling in early involution. J Mammary Gland Biol Neoplasia 2007;12:3-13.
28. Gross M, Liu B, Tan J, French FS, Carey M, Shuai K. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 2001;20:3880-3887
29. Sonnenblick A, Levy C, Razin E. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol 2004;24:10584-10592
30. Kotaja N, Karvonen V, Jänne OA, Palvimo JJ. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 2002;22:5222-5234
31. Rödel B, Tavassoli K, Karsunky H, et al. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J 2000;19:5845-5855
32. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009;136:823-837
33. Chapman RS, Lourenco P, Tonner E, et al. The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol 2000;480:129-138 Review.
34. Zhang Q, Raghunath PN, Xue L, et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol 2002;168:466-474
35. Qu J, Liu GH, Wu K, et al. Nitric oxide destabilizes Pias3 and regulates sumoylation. PLoS ONE 2007;2:e1085.
36. Depaux A, Reginier-Ricard F, Germani A, Varin-Blank N. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation. Oncogene 2007;26:6665-6676
37. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008;9:102-114
38. Levy C, Lee YN, Nechushtan H, et al. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. Blood 2006;107:2839-2845 Epub 2005 Dec 20.
39. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003;63:1270-1279
40. Dourlat J, Liu WQ, Sancier F, et al. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity. Biochimie 2009;91:996-1002. Epub 2009 May 24.
41. Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006;13:1235-1242
42. Siddiquee KA, Gunning PT, Glenn M, et al. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem Biol 2007;2:787-798
43. Tadlaoui Hbibi A, Laquillier C, Souissi I, et al. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotideinterference with interferon-γ-STAT1-mediated killing. FEBS J 2009;276:2505-2515 Epub 2009 May 24.